company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,87853000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,75000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3244000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,91172000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15150000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,155000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,435000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,590000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,,totalassets,Total Assets,=,debit,usd,106912000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,13405000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3689000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5515000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22609000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,400000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3579000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1637000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5616000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,28225000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,295993000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-217306000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,78687000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,78687000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,78687000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q1,,2014-03-31,2014-05-14 17:01:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,106912000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,203308000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,75000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3175000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,206558000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16324000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,435000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,435000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,,totalassets,Total Assets,=,debit,usd,223317000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,11045000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2687000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5033000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18765000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,703000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3627000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1714000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6044000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,24809000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,429116000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-230608000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,198508000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,198508000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,198508000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q2,,2014-06-30,2014-08-13 17:23:21+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,223317000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,187486000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,75000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3349000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,190910000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17394000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,183000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,435000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,618000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,,totalassets,Total Assets,=,debit,usd,208922000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,8764000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2666000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3317000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,14747000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,938000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3676000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1647000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6261000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21008000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,432499000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-244585000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,187914000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,187914000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,187914000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2014.0,Q3,,2014-09-30,2014-11-13 17:13:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,208922000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,153717000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,35000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1937000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,155689000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19390000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,243000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,643000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,,totalassets,Total Assets,=,debit,usd,175722000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2089000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4019000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,319000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6427000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,513000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3741000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1583000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5837000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12264000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,437657000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-274199000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,163458000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,163458000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,163458000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q1,,2015-03-31,2015-05-14 16:34:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,175722000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,96417000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,35000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,38884000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1920000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,137256000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19134000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,14052000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,374000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,14826000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,,totalassets,Total Assets,=,debit,usd,171216000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2211000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5040000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2906000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10157000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,6973000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3751000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1494000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,12218000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22375000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,439857000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-291004000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-12000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,148841000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,148841000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,148841000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q2,,2015-06-30,2015-08-07 16:18:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,171216000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90494000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,35000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,51364000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1604000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,143497000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19254000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,2357000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,6000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,400000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2763000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,,totalassets,Total Assets,=,debit,usd,165514000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2731000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5990000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3018000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11739000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,6176000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3762000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1481000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11419000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,23158000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,452525000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-310179000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,142356000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,142356000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,142356000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2015.0,Q3,,2015-09-30,2015-11-10 17:11:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,165514000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,40793000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,195815000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1882000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,238490000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,19714000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,216000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,796000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,,totalassets,Total Assets,=,debit,usd,259000000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3307000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5925000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3256000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12488000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,4486000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3746000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1428000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9660000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,22148000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,588827000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-352161000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,186000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,236852000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,236852000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,236852000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q1,,2016-03-31,2016-05-10 16:11:09+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,259000000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52651000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,164293000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1613000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,218557000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17658000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,214000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,794000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,,totalassets,Total Assets,=,debit,usd,237009000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2982000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5622000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3314000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,11918000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,3659000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3714000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1942000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,9315000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,21233000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,592390000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-376762000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,148000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,215776000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,215776000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,215776000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q2,,2016-06-30,2016-08-05 16:08:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,237009000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,130481000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,70770000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7428000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,208679000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17385000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,213000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,793000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,,totalassets,Total Assets,=,debit,usd,226857000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2871000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11306000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3339000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17516000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,2836000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3681000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2109000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8626000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,26142000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,595440000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-394741000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,16000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,200715000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,200715000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,200715000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2016.0,Q3,,2016-09-30,2016-11-04 16:11:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,226857000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38235000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,502000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,150404000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8312000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,197453000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11205000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,216000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,796000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,,totalassets,Total Assets,=,debit,usd,209454000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5573000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14967000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3502000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,24042000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,983000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3576000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2182000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6741000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,30783000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,627505000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-448736000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-98000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,178671000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,178671000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,178671000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q1,,2017-03-31,2017-05-09 17:12:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,209454000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,53693000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentassets,restrictedcash,Restricted Cash,+,debit,usd,502000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,111852000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8306000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,174353000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11255000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,888000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1468000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,,totalassets,Total Assets,=,debit,usd,187076000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4079000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14347000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3550000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21976000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3497000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2189000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5686000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,27662000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,635138000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-475610000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-114000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,159414000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,159414000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,159414000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q2,,2017-06-30,2017-08-04 17:08:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,187076000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56323000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,97117000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2827000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,156267000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11500000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,836000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1416000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,,totalassets,Total Assets,=,debit,usd,169183000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6680000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12069000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2727000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,21476000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,3418000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2233000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,5651000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,27127000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,648360000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-506261000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,142056000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,142056000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,142056000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2017.0,Q3,,2017-09-30,2017-11-03 16:28:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,169183000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,69212000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,199594000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4612000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,273418000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10064000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,718000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,580000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1298000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,,totalassets,Total Assets,=,debit,usd,284780000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5361000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11120000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5532000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,983000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,22996000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,22496000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2647000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25143000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,48139000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,814121000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-577204000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-276000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,236641000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,236641000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,236641000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q1,,2018-03-31,2018-05-09 17:18:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,284780000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,39282000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,194452000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9148000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,242882000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,12196000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3315000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,730000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4045000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,,totalassets,Total Assets,=,debit,usd,259123000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5435000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13569000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9320000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,28324000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,18227000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2717000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,20944000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,49268000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,821363000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-611284000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-224000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,209855000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,209855000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,209855000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q2,,2018-06-30,2018-08-03 17:25:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,259123000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,45132000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,163260000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7492000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,215884000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13493000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2944000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,730000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3674000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,,totalassets,Total Assets,=,debit,usd,233051000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7341000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15718000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,8749000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,31808000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,16382000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2763000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,19145000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,50953000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,826389000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-644158000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-133000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,182098000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,182098000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,182098000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2018.0,Q3,,2018-09-30,2018-11-02 16:06:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,233051000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65269000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,205719000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6128000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,277116000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15378000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,31251000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,730000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,31981000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,,totalassets,Total Assets,=,debit,usd,324475000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4486000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13521000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13054000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3009000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34070000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,28517000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37940000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2845000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,69302000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,103372000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,941112000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-720100000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,70000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,221082000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,221103000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,221103000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q1,,2019-03-31,2019-05-09 16:04:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,324475000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90034000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,151858000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8013000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,249905000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15263000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,29994000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,730000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30724000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,,totalassets,Total Assets,=,debit,usd,295892000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7966000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14737000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,18825000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3168000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44696000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,27661000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,32169000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2824000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,62654000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,107350000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,945895000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-757469000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,116000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,188542000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,188542000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,188542000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q2,,2019-06-30,2019-08-06 16:16:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,295892000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,58922000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,150110000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5000000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6536000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,220568000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14917000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,29597000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalnoncurrentassets,othernoncurrentnonoperatingassets,Other Noncurrent Nonoperating Assets,+,debit,usd,730000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,30327000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,,totalassets,Total Assets,=,debit,usd,265812000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6902000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18694000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,5241000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3317000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,34154000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,26778000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,50707000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2892000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,80377000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,114531000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,950117000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-798900000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,42000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,151259000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,151281000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,151281000.0
Revance Therapeutics Inc,RVNC,549300N33TFDZHS81H11,0001479290,2019.0,Q3,,2019-09-30,2019-11-04 16:14:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,265812000.0
